As a certified QE, PurpleLab® reports annually on industry-standard quality measures. This edition focuses on kidney health monitoring for diabetic patients, examining attainment trends and disparities by payer type and state from 2020 to 2024. This claims-based measure evaluates whether diabetic patients at risk of Chronic Kidney Disease (CKD) complete three tests within a calendar year: Estimated Glomerular Filtration Rate (eGFR) Quantitative Urine Albumin Urine Creatinine Download PurpleLab’s 2026 QE Standard Measures Report, based on CMS MIPS Measure Quality ID #488: Kidney Health Evaluati